MDB Stock Overview
A biotechnology company, provides medicines, medicinal products, and biotechnology products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Medicofarma Biotech SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.41 |
| 52 Week High | zł1.25 |
| 52 Week Low | zł0.34 |
| Beta | 3.05 |
| 11 Month Change | -21.15% |
| 3 Month Change | -21.15% |
| 1 Year Change | -63.06% |
| 33 Year Change | -79.27% |
| 5 Year Change | 32.26% |
| Change since IPO | -68.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDB | PL Life Sciences | PL Market | |
|---|---|---|---|
| 7D | 5.1% | -7.4% | -3.1% |
| 1Y | -63.1% | -17.7% | -1.7% |
Return vs Industry: MDB underperformed the Polish Life Sciences industry which returned -17.7% over the past year.
Return vs Market: MDB underperformed the Polish Market which returned -1.7% over the past year.
Price Volatility
| MDB volatility | |
|---|---|
| MDB Average Weekly Movement | 9.5% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: MDB's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: MDB's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 21 | Cezary Kilczewski | medicofarmabiotech.pl |
Medicofarma Biotech SA, a biotechnology company, provides medicines, medicinal products, and biotechnology products. The company is involved in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. It also offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics; and covid-19 test kits, such as real time PCR genetic tests.
Medicofarma Biotech SA Fundamentals Summary
| MDB fundamental statistics | |
|---|---|
| Market cap | zł27.87m |
| Earnings (TTM) | -zł2.73m |
| Revenue (TTM) | zł1.37m |
20.4x
P/S Ratio-10.2x
P/E RatioIs MDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDB income statement (TTM) | |
|---|---|
| Revenue | zł1.37m |
| Cost of Revenue | zł1.16m |
| Gross Profit | zł210.93k |
| Other Expenses | zł2.94m |
| Earnings | -zł2.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 15.41% |
| Net Profit Margin | -199.64% |
| Debt/Equity Ratio | 17.4% |
How did MDB perform over the long term?
See historical performance and comparison